Literature DB >> 23179615

Engineering E. coli for caffeic acid biosynthesis from renewable sugars.

Haoran Zhang1, Gregory Stephanopoulos.   

Abstract

Caffeic acid is a valuable aromatic compound that possesses many important pharmacological activities. In structure, caffeic acid belongs to the hydroxycinnamic acid family and can be biosynthesized from the aromatic amino acid tyrosine. In the present paper, the caffeic acid biosynthesis pathway was reconstituted in engineered Escherichia coli to produce caffeic acid from simple biomass sugar glucose and xylose. Different engineering approaches were utilized to optimize the production. Specifically, two parallel biosynthesis routes leading from tyrosine to caffeic acid were studied. The copy number of the intermediate biosynthesis genes was varied to find appropriate gene doses for caffeic acid biosynthesis. Three different media, including a MOPS medium, a synthetic medium, and a rich medium, were also examined to improve the production. The highest specific caffeic acid production achieved was 38 mg/L/OD. Lastly, cultivation of engineered E. coli in a bioreactor resulted in a production of 106 mg/L caffeic acid after 4 days.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23179615     DOI: 10.1007/s00253-012-4544-8

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  23 in total

Review 1.  Heterologous production of curcuminoids.

Authors:  J L Rodrigues; K L J Prather; L D Kluskens; L R Rodrigues
Journal:  Microbiol Mol Biol Rev       Date:  2015-03       Impact factor: 11.056

Review 2.  Heterologous production of resveratrol in bacterial hosts: current status and perspectives.

Authors:  A Braga; P Ferreira; J Oliveira; I Rocha; N Faria
Journal:  World J Microbiol Biotechnol       Date:  2018-07-27       Impact factor: 3.312

Review 3.  Recent Advances in Metabolically Engineered Microorganisms for the Production of Aromatic Chemicals Derived From Aromatic Amino Acids.

Authors:  Yu-Ping Shen; Fu-Xing Niu; Zhi-Bo Yan; Lai San Fong; Yuan-Bin Huang; Jian-Zhong Liu
Journal:  Front Bioeng Biotechnol       Date:  2020-05-05

4.  Production of acrylic acid and propionic acid by constructing a portion of the 3-hydroxypropionate/4-hydroxybutyrate cycle from Metallosphaera sedula in Escherichia coli.

Authors:  Zhijie Liu; Tiangang Liu
Journal:  J Ind Microbiol Biotechnol       Date:  2016-10-08       Impact factor: 3.346

5.  Construction of a chimeric biosynthetic pathway for the de novo biosynthesis of rosmarinic acid in Escherichia coli.

Authors:  Sarah E Bloch; Claudia Schmidt-Dannert
Journal:  Chembiochem       Date:  2014-09-09       Impact factor: 3.164

Review 6.  Biotechnological production of specialty aromatic and aromatic-derivative compounds.

Authors:  A Braga; N Faria
Journal:  World J Microbiol Biotechnol       Date:  2022-03-26       Impact factor: 3.312

7.  Artificial de novo biosynthesis of hydroxystyrene derivatives in a tyrosine overproducing Escherichia coli strain.

Authors:  Sun-Young Kang; Oksik Choi; Jae Kyoung Lee; Jung-Oh Ahn; Jong Seog Ahn; Bang Yeon Hwang; Young-Soo Hong
Journal:  Microb Cell Fact       Date:  2015-06-10       Impact factor: 5.328

8.  Production of hydroxycinnamoyl-shikimates and chlorogenic acid in Escherichia coli: production of hydroxycinnamic acid conjugates.

Authors:  Bong-Gyu Kim; Woo Dam Jung; Hyejung Mok; Joong-Hoon Ahn
Journal:  Microb Cell Fact       Date:  2013-02-05       Impact factor: 5.328

Review 9.  Analytics for Metabolic Engineering.

Authors:  Christopher J Petzold; Leanne Jade G Chan; Melissa Nhan; Paul D Adams
Journal:  Front Bioeng Biotechnol       Date:  2015-09-07

10.  Overexpression of artificially fused bifunctional enzyme 4CL1-CCR: a method for production of secreted 4-hydroxycinnamaldehydes in Escherichia coli.

Authors:  Shuxin Liu; Qi Qi; Nan Chao; Jiayin Hou; Guodong Rao; Jin Xie; Hai Lu; Xiangning Jiang; Ying Gai
Journal:  Microb Cell Fact       Date:  2015-08-12       Impact factor: 5.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.